Investors may find this useful:-
Source: The Motley Fool Australia Warning: Every investor should read this before buying speculative biotech companies
https://search.app/KrD51ZJ6TjZSaafV8
My investment is pure speculation and not a king’s ransom. I’d be happier if SNT starts to think strategic eg future finance looking, like merging to protect its IP. As it looks ATM the company isn’t generating sufficient revenue to sustain its R&D program. It will need to re-finance at some stage in 2024/25. My opinion only.
Investors may find this useful:-Source: The Motley Fool...
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $42.58M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.3¢ | 3.3¢ | $6.417K | 194.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 106747 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 228097 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| SNT (ASX) Chart |